• share
• favorite_border

Not all older adults were offended by public health messaging, but they were affected in other ways

• share
• favorite_border

Many groups participate in the communication of science, including investigators and researchers, professional organizations, federal agencies, foundations, industry, editors and science writers.

• share
• favorite_border

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 “breakthrough” infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

• share
• favorite_border

A team at University Hospitals in Cleveland aims to unearth potential immunologic mechanisms and understanding of COVID-19 upon long-term consequences and outcomes thanks to a grant from the American Lung Association.

• share
• favorite_border

A new study from the Lab of Fangqiong Ling at the McKelvey School of Engineering will help facilitate the exchange of data and results between engineers and medical researchers, leading to a more robust understanding of the relationships between viruses moving through the engineered world and diseases spreading through populations.

• share
• favorite_border

The halting, confusing response to COVID-19 in the U.S. resulted from decisions by President Donald Trump and his allies to politicize the pandemic by associating it with his own fate in office, according to a new book by a Cornell author.

• share
• favorite_border

It’s that time of year: costumes, candy and trick-or-treating. As families celebrate this season, Johns Hopkins Children’s Center experts are available for interviews on a variety of tips to help ensure a safe and fun Halloween.

• share
• favorite_border

A new poll shows that 48% of people age 50 to 80 have bought at least one kind of at-home health test, including 32% who had bought COVID-19 tests, 17% who had bought a DNA test, and lower percentages who had bought other types of tests. But use of such direct-to-consumer medical tests varies greatly by age, race/ethnicity, marital status, income and years of education.

• share
• favorite_border

New Washington University in St. Louis research suggests those touched by the sometimes devastating effects of the COVID-19 pandemic are now more likely to recognize sources of inequality and, in turn, advocate for greater equality in the United States.

• share
• favorite_border

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients. Researchers say the findings reinforce COVID-19 as a pulmonary disease with multi-organ injury related to systemic inflammation. However, they conclude results should not minimize the fact that patients with cardiovascular disease are still at risk for death due to COVID-19, as they have a high burden of risk factors for the disease.

• share
• favorite_border

A team of researchers at the University of Miami Miller School of Medicine have uncovered a potential approach for treating patients with serious long-term COVID conditions. In two recent studies using experimental models, they found that placing a peptide “net” around the spike protein on the virus reduced deaths from organ failure and improved overall outcomes.

• share
• favorite_border

Programs that distributed more than 2 million at-home COVID-19 tests to counties in North Carolina, Tennessee, and California with large underrepresented racial and ethnic populations were successful in getting test kits into the hands of community members and changing people’s behaviors in support of public health.

• share
• favorite_border

“Smart surveillance” for viral spillover from animals to humans, targeted preparedness & drug/vaccine research, & worldwide cooperation on stopping disease spread are required to reduce deaths & lessen economic consequences of the next pandemic, according to an international team of scientists.

• share
• favorite_border

New COVID-19 variants could potentially be contained where they arise using genetic sequencing, a new study from the University of Georgia has found. But it will require global cooperation. Published in PNAS Nexus, the study found that standard methods that first assess a new variant’s severity are too slow to stop its spread. Next-generation genetic sequencing, however, offers a feasible alternative to spot new variants with enough time to contain variants where they first appear.

• share
• favorite_border

Four of 10 Americans surveyed report that they were often less than truthful about whether they had COVID-19 and/or didn’t comply with many of the disease’s preventive measures during the height of the pandemic, according to a new nationwide study.

• share
• favorite_border

A Cleveland Clinic-led research team used artificial intelligence to map out hundreds of ways that the virus that causes COVID-19 interacts with infected cells. Through this analysis, they identified potential COVID-19 medicines within thousands of drugs already approved by the FDA for other treatments. The research focused on host-targeting therapies, which operate differently from other antivirals by disrupting the mechanisms viruses use to multiply and survive, rather than just blocking specific proteins within the cell. The research, published in Nature Biotechnology, presents a network called an “interactome,” the interactions between COVID-19 virus proteins and host cell proteins.

• share
• favorite_border

University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The genes control the immune system of the host, contributing to how fiercely the body responds to a COVID-19 infection.

• share
• favorite_border

New data from Rwanda, and some of the first published on how COVID-19 has impacted school attendance in the Global South, suggest that a widely-predicted spike in drop-out rates has “not materialised”.

• share
• favorite_border

Building a disease model they created last year, researchers at ISU find accounting for ethnicity and social factors may improve strategies for future pandemics.

• share
• favorite_border

A research team led by a University of Massachusetts Amherst scientist has made a significant genetic discovery that sheds light on the use of the drug caspofungin to treat a deadly fungal infection, Aspergillus fumigatus, which kills some 100,000 severely immunocompromised people each year.

• share
• favorite_border

Finding new ways to treat the novel coronavirus and its ever-changing variants has been a challenge for researchers, especially when the traditional drug development and discovery process can take years. A Michigan State University researcher and his team are taking a hi-tech approach to determine whether drugs already on the market can pull double duty in treating new COVID variants.

• share
• favorite_border

Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine.

• share
• favorite_border

SARS-CoV-2, the virus that causes COVID-19, is an airborne disease transmitted via aerosols, which are spread from the oral and nasal cavities—the mouth and the nose.

• share
• favorite_border

An international team of researchers has demonstrated that among patients hospitalized for influenza, those who were vaccinated had less severe infections, including reducing the odds for children requiring admittance to an intensive care unit by almost half.

• share
• favorite_border

New findings published in the Nicotine and Tobacco Research journal by UC Davis Comprehensive Cancer tobacco researchers may lead to urgent recommendations for doctors to help patients quit smoking as a way of countering COVID-19.

• share
• favorite_border

Tufts University School of Medicine Chair of Psychiatry Paul Summergrad discusses the pandemic’s impact on mental health and what needs to be done to improve access to care

• share
• favorite_border

In a new study published online ahead of print in the journal Vaccine, Moffitt Cancer Center researchers identify factors associated with high and low COVID-19 vaccine acceptance among cancer patients.

• share
• favorite_border

In one of the largest single-center COVID-19 cohort studies to date, researchers at the Icahn School of Medicine at Mount Sinai, using samples collected during the peak of the pandemic in New York City, have identified a key driver of COVID-19 disease severity.

• share
• favorite_border

A method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.

• share
• favorite_border

Rutgers Robert Wood Johnson Medical School’s Department of Pediatrics recently launched a website that presents multilingual resources about COVID-19 vaccines in children and young adults.

• share
• favorite_border

An obscure family of viruses, already endemic in wild African primates and known to cause fatal Ebola-like symptoms in some monkeys, is “poised for spillover” to humans, according to new University of Colorado Boulder research published online Sept. 30 in the journal Cell.